focus
Previous article:
Walensky prepares to leave CDC — and Congress — behind
Next article: Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves
Next article: Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves
focus
knowledge
-
Beware the threat of staffing cuts at the CDC
2025-10-08 15:24 -
New documents shed light on MD Anderson Cancer Institute feud
2025-10-08 15:15 -
PBM reform efforts get punted in Congress
2025-10-08 15:09 -
Beware the threat of staffing cuts at the CDC
2025-10-08 14:48 -
PBM reform efforts get punted in Congress
2025-10-08 13:54 -
Neurocrine Biosciences, biotech based in San Diego, joins PhRMA
2025-10-08 12:44